Published on in Vol 12 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/58456, first published
.
Journals
- Pradhan A, Lussier M, Nguyen M, Voyce S, Wright E. Qualitative evaluation to understand barriers and facilitators to prescribing angiotensin receptor-neprilysin inhibitors (ARNi) and sodium-glucose cotransporter inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF). Journal of the American Pharmacists Association 2024;64(6):102224 View